Effects of Δ9-tetrahydrocannabinol on the levels of cyclic adenosine 3',5'-monophosphate in mouse brain☆
References (51)
- et al.
Brain Res.
(1972) - et al.
Brain Res.
(1971) - et al.
J. biol. Chem.
(1962) - et al.
Brain Res
(1972) - et al.
Analyt. Biochem.
(1971) - et al.
J. biol. Chem.
(1969) - et al.
Archs Biochem. Biophys.
(1966) - et al.
J. biol. Chem.
(1970) - et al.
Lancet
(1970) - et al.
Lancet
(1970)
Eur. J. Pharmac.
(1971)
Nature, Lond.
(1970)
Science, N.Y.
(1971)
Science, N.Y.
(1970)
Science, N.Y.
(1972)
J. Am. chem. Soc.
(1964)
Science, N.Y.
(1971)
Clin. Pharmac. Ther.
(1968)
Psychophuarmacologia
(1967)
Science, N.Y.
(1971)
Science, N.Y.
(1972)
Science, N.Y.
(1970)
Science, N.Y.
(1970)
Science, N.Y.
(1970)
Science, N.Y.
(1972)
Cited by (19)
Progress toward Understanding the Cannabinoid Receptor and Its Second Messenger Systems
1994, Advances in PharmacologyChronic marijuana smoke exposure in the rhesus monkey IV: Neurochemical effects and comparison to acute and chronic exposure to delta-9-tetrahydrocannabinol (THC) in rats
1991, Pharmacology, Biochemistry and BehaviorThe central neuropharmcology of psychotropic cannabinoids
1988, Pharmacology and TherapeuticsEffects of acute cannabis use on urinary neurotransmitter metabolites and cyclic nucleotides in man
1984, Drug and Alcohol DependencePossible role of prostaglandins in the effects of the cannabinoids on adenylate cyclase activity
1983, European Journal of Pharmacology
- ☆
Supported in part by Grant 5RO1 DA00116 (formerly MH 21003) from the National Institute of Mental Health.
Copyright © 1974 Published by Elsevier Inc.